Journal Article

Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-<i>ras</i> mutations, in v-Ha-<i>ras</i> transgenic Tg.AC mice

Laura A. Hansen, Carol S. Trempus, Joel F. Mahler and Raymond W. Tennant

in Carcinogenesis

Volume 17, issue 9, pages 1825-1833
Published in print September 1996 | ISSN: 0143-3334
Published online September 1996 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/17.9.1825
Association of tumor development with increased cellular
                    proliferation and transgene overexpression, but not c-Ha-ras
                    mutations, in v-Ha-ras transgenic Tg.AC mice

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

The transgenic mouse line TgAC carries a v-Ha-ras gene fused to a fetal (ζ) globin promoter and uniquely responds to chemical carcinogens and tumor promotors by the induction of epidermal papillomas. Although the transgene was not constitutively expressed in non-tumor-bearing tissues, expression was induced by exposure to selected chemicals. Tg.AC transgenic mice on the FVB/N background developed occasional spontaneous tumors, including odontomas, squamous cell carcinoma of the salivary gland, leukemias and a rare ovarian yolk sac carcinoma. Both spontaneous and induced tumors are associated with expression of the transgene and, as determined by in situ hybridization, transgene expression is localized to proliferative areas of the tumors. Sequence analysis of the endogenous c-Ha-ras gene in both induced and spontaneous tumors revealed no mutations in codons 12, 59 or 61. These results suggest that expression of the v-Ha-ras transgene induces proliferation of specific cells in diverse tissues which then acquire neoplastic properties.

Journal Article.  0 words. 

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.